MINERVA SURGICAL INC
Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | |
|---|---|---|---|
| Revenue | $50.3M | $52.1M | $37.8M |
| Operating income | −$30.9M | −$29.1M | −$15.4M |
| Net income | −$34.1M | −$21.5M | −$18.3M |
| Total assets | $68.9M | $115.1M | $92.0M |
| Total liabilities | $51.7M | $71.0M | $190.6M |
| Equity | $17.2M | $44.1M | −$221.8M |
| EPS (diluted) | $-1.18 | $-3.06 | — |
| Shares out. | 28.8M | 28.8M | 1.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −61.4%
- Net margin
- −67.8%
- Return on equity
- −198.5%
- Return on assets
- −49.5%
- Return on capital (ROCE)
- −56.6%
- Liabilities / assets
- 75.1%
- Debt / equity
- 3.01×
- Book value / share
- $0.60
- Revenue growth (YoY)
- −3.5%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -14.01distress
- Accruals / assets
- 2.1%clean
- Beneish M-Score
- -2.23normal
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 5 warning● 1 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| New Enterprise Associates 13 Lp10% owner | Feb 9, 2023 | Buy | 24.4M | $0.20 |
| Skalnyi Evgueni V.Officer — VP Medical Affairs | May 2, 2022 | Grant | 49,755 | $0.00 |
| Filloux Dominique J.Officer — COO | May 2, 2022 | Grant | 60,198 | $0.00 |
| Jung Joel ROfficer — CFO | May 2, 2022 | Grant | 60,198 | $0.00 |
| Clapper David MOfficer — President and CEO | May 2, 2022 | Grant | 229,732 | $0.00 |
| Sung DerrickDirector | Jul 19, 2022 | Grant | 86,956 | $2.30 |
| Behbahani AliDirector | Jun 10, 2022 | Grant | 49,792 | $2.41 |
| Jaffe Ross A MdDirector | Jun 10, 2022 | Grant | 49,792 | $2.41 |
| Renzi DavidDirector | Jun 10, 2022 | Grant | 49,792 | $2.41 |
| Hunt Niquette L.Director | Jun 10, 2022 | Grant | 49,792 | $2.41 |
| Coste CatherineDirector | Jun 10, 2022 | Grant | 49,792 | $2.41 |
| Anderson JillDirector | Jun 10, 2022 | Grant | 49,792 | $2.41 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Delisting / listing-standard notice · Regulation FD disclosureDec 15, 2023
- Results of operationsNov 13, 2023
- Other material eventNov 2, 2023
- Director / officer changeOct 13, 2023
- Modified shareholder rights · Amended charter or bylawsSep 29, 2023
- Entered a material agreement · Unregistered equity sale · Regulation FD disclosureSep 28, 2023
- Results of operationsAug 2, 2023
- Director / officer change · Other material eventJul 7, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.